Join Our 20,000+ Subscribers. Get Weekly News Sent To Your Email
Subscribe to our newsletter and stay updated on the latest Critical Care Medicine related news.
See Past Critical Care Newsletter issues

Subscribe to Newsletter

Bifunctional drug could treat tumors resistant to current mTOR inhibitors

2minutemedicine.com October 1, 2016

The first known bifunctional inhibitor for the mechanistic target of rapamycin (mTOR) protein was developed to overcome current known mechanisms of tumor resistance to mTOR inhibitors.

cancer drugs inhibitors treatment tumors

Managing Blood Glucose Control in the ICU

COVID-19 and the Cardiovascular System: From Pathophysiology to Clinical Management

COVID-19 and the Cardiovascular System: From Pathophysiology to Clinical Management

ICU Protocols: A Step-wise Approach, Vol II

ICU Protocols: A Step-wise Approach, Vol II

COVID-19 Pneumonia: Different Respiratory Treatments for Different Phenotypes?

RRT Board Exam: Mechanical Ventilation

ICU Manual

The Ultimate Guide to Point-of-Care Ultrasound-Guided Procedures

Pediatric Acute Respiratory Distress Syndrome

Miracle Cure: The Creation of Antibiotics and the Birth of Modern Medicine

Acute Respiratory Distress Syndrome: Advances in Diagnostic Tools and Disease Management

ICU Quick Drug Guide

Hemodynamic Monitoring Using Echocardiography in the Critically Ill

The Washington Manual of Critical Care 4th Edition

Quick Reference to Critical Care

Bedside Procedures in the ICU

Trauma Team Dynamics: A Trauma Crisis Resource Management Manual

EKG/ECG Interpretation Made Easy

Evidence-Based Critical Care: A Case Study Approach

Clinical Examination Skills in the Adult Critically Ill Patient